Stocks
ImmunoGen (IMGN) EBITDA margin US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -285.1% | -79.9% | -14.9% | -177.8% | -198.3% | 14.6% | ||
| Changes by years, y/y, % | -222pp | +205pp | +65pp | -163pp | -21pp | +25.6% | |||
ImmunoGen. EBITDA margin, %
ImmunoGen. EBITDA margin, changes, pp
ImmunoGen (IMGN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| EBITDA margin, % | ? | 27.0% | -2.24% | -2.76% | 27.0% | 27.4% | 14.6% | |
| Changes by years, y/y, % | +534pp | +427pp | +129pp | +103pp | +535pp | |||
| Changes by quarters, q/q, % | +103pp | -29pp | -1pp | +30pp | +0pp | |||
